检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:詹琼[1] 许顶立[1] ZHAN Qiong;XU Dingli(Department of Cardiology,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China)
机构地区:[1]南方医科大学南方医院心内科,广州510515
出 处:《心电与循环》2025年第2期126-131,共6页Journal of Electrocardiology and Circulation
摘 要:心力衰竭(下称心衰)与肾功能不全的共病现象在临床中极为常见,两者互为因果,形成机制复杂的恶性循环。近年来,随着心衰治疗药物的不断研发,循证医学的发展,心衰合并肾功能不全的诊疗策略发生了革新,在治疗全程中动态评估肾功能,针对不同慢性肾脏病分期调整药物选择,强调了个体化治疗的重要性。本文通过心衰合并肾功能不全的流行病学、机制、评价指标及生物标志物、心衰治疗药物的使用等方面对心衰合并肾功能不全的诊疗进展作一述评。The comorbidity of heart failure and renal insufficiency is extremely common in clinical practice.These two conditions are both causes and effects of each other,forming a complex vicious cycle in terms of mechanism.In recent years,with the continuous research and development of drugs for treating heart failure and the development of evidence-based medicine,the diagnosis and treatment strategies for heart failure complicated with renal insufficiency have been innovated.Dynamically evaluating renal function throughout the treatment process,adjusting the selection of drugs according to different stages of chronic kidney disease,and emphasizing the importance of individualized treatment.This article will systematically elaborate on the current status and progress of the diagnosis and treatment of heart failure complicated with renal insufficiency.
分 类 号:R541.6[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.7